Replimune (REPL) Shares Outstanding (Diluted) (2020 - 2026)
Replimune (REPL) posted Shares Outstanding (Diluted) of 96.86 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 5.8% from 91.52 million a year earlier and up 4.4% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Replimune's Shares Outstanding (Diluted) came in at 92.8 million, up 15.2% from FY2025.
- Annual Shares Outstanding (Diluted) has increased for five consecutive fiscal years, with a five-year compound annual growth rate of 14.9% (FY2021 to FY2026).
- In prior fiscal years, Replimune's Shares Outstanding (Diluted) was 80.56 million in FY2025 (+21.0%), 66.57 million in FY2024 (+14.4%), 58.21 million in FY2023 (+11.5%) and 52.21 million in FY2022 (+12.9%).
- The fiscal Q1 2027 figure stands as the highest quarterly Shares Outstanding (Diluted) in data going back to fiscal Q1 2021.
- On a year-over-year basis, Shares Outstanding (Diluted) has increased in each of the last 21 quarters, with growth averaging 18.1% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Diluted) has ranged between 4.2% (fiscal Q1 2025) and 32.3% (fiscal Q1 2026) over the last five years.
- According to Business Quant data, Shares Outstanding (Diluted) for the three prior fiscal quarters was 92.8 million (Q4 2026), 92.19 million (Q3 2026) and 91.92 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Replimune | 1.11 Bn | 1.11 Bn | - | 96.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.86 Mn |
| Mar 31, 2026 | 92.80 Mn |
| Dec 31, 2025 | 92.19 Mn |
| Sep 30, 2025 | 91.92 Mn |
| Jun 30, 2025 | 91.52 Mn |
| Mar 31, 2025 | 80.56 Mn |
| Dec 31, 2024 | 83.50 Mn |
| Sep 30, 2024 | 78.57 Mn |
| Jun 30, 2024 | 69.19 Mn |
| Mar 31, 2024 | 66.57 Mn |
| Dec 31, 2023 | 66.65 Mn |
| Sep 30, 2023 | 66.58 Mn |
| Jun 30, 2023 | 66.37 Mn |
| Mar 31, 2023 | 58.21 Mn |
| Dec 31, 2022 | 57.86 Mn |
| Sep 30, 2022 | 54.77 Mn |
| Jun 30, 2022 | 54.21 Mn |
| Mar 31, 2022 | 52.21 Mn |
| Dec 31, 2021 | 52.32 Mn |
| Sep 30, 2021 | 52.08 Mn |
API Access
Replimune Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();